• Home
• Our products
• Vaccines

Vaccines

We market over 25 vaccines worldwide to prevent potentially life-threatening or crippling illnesses such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza and bacterial meningitis.

The majority of our vaccine R&D activities are conducted at GlaxoSmithKline Biologicals in Rixensart, Belgium. Over 1300 of our research scientists are devoted to developing new vaccines and more cost-effective and convenient combination vaccines to prevent infections that cause serious medical problems worldwide.

We are also targeting therapeutic vaccines that may prevent relapse in cancer patients. The strength of our vaccine pipeline will provide opportunities for us to consistently deliver new vaccines for many years to come.

Here you will find the Patient Information Leaflets or Prescribing Information for our vaccines. Please note that this information is often specific to a country or region and is not intended to replace the advice of a qualified doctor.

Products are in various stages of approval around the world and may not be available in every country.

• ACWY Vax
• meningococcal polysaccharides serogroups A, C, W135 and Y
• Ambirix
• Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)
• Boostrix
• tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed
• Cervarix
• Human Papillomavirus vaccine (types 16, 18) - recombinant, adjuvanted, adsorbed
• Engerix-B
• Hepatitis B Vaccine (Recombinant)
• Fendrix
• Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)
• Fluarix
• influenza vaccine
• FluLaval
• influenza vaccine
• Havrix
• hepatitis A vaccine, inactivated
• Hepatyrix
• Hepatitis A (inactivated, adsorbed) and Typhoid Polysaccharide vaccine
• Hiberix
• haemophilus B conjugate vaccine (tetanus toxoid conjugate)
• Infanrix
• diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed
• Infanrix IPV
• diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed)
• Infanrix IPV + HIB
• diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) and Haemophilus influenzae serotype b conjugate vaccine (adsorbed)
• Kinrix
• diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine
• Menitorix
• combined Haemophilus influenzae type b and Neisseria meningitidis group C (Hib-MenC) conjugate vaccines
• Pandemrix
• influenza vaccine (split virion, inactivated)
• Pediarix
• diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated poliovirus vaccine combined
• Priorix
• measles, mumps and rubella vaccine (live attenuated virus)
• Rotarix
• human rotavirus vaccine, live attenuated
• Synflorix
• Pneumococcal polysaccharide conjugate vaccine (adsorbed)
• Twinrix
• combined hepatitis A (inactivated virus) and hepatitis B vaccine (genetically derived surface antigen)
• Typherix
• typhoid vaccine (purified polysaccharide antigen)
• Varilrix
• varicella in healthy adults and adolescents